Shigeyuki Chaki. Pharmacol Biochem Behav 2020
Times Cited: 2
Times Cited: 2
Times Cited
Times Co-cited
Similarity
Mechanisms of ketamine and its metabolites as antidepressants.
Evan M Hess, Lace M Riggs, Michael Michaelides, Todd D Gould. Biochem Pharmacol 2022
Evan M Hess, Lace M Riggs, Michael Michaelides, Todd D Gould. Biochem Pharmacol 2022
100
The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice.
Anna Rafało-Ulińska, Agnieszka Pałucha-Poniewiera. Behav Brain Res 2022
Anna Rafało-Ulińska, Agnieszka Pałucha-Poniewiera. Behav Brain Res 2022
50
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Chun Yang, Shizuka Kobayashi, Kazuhito Nakao, Chao Dong, Mei Han, Youge Qu, Qian Ren, Ji-Chun Zhang, Min Ma, Hidetoh Toki,[...]. Biol Psychiatry 2018
Chun Yang, Shizuka Kobayashi, Kazuhito Nakao, Chao Dong, Mei Han, Youge Qu, Qian Ren, Ji-Chun Zhang, Min Ma, Hidetoh Toki,[...]. Biol Psychiatry 2018
50
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review.
J John Mann, Christina A Michel, Randy P Auerbach. Am J Psychiatry 2021
J John Mann, Christina A Michel, Randy P Auerbach. Am J Psychiatry 2021
50
An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Kai Zhang, Kenji Hashimoto. Expert Rev Neurother 2019
Kai Zhang, Kenji Hashimoto. Expert Rev Neurother 2019
50
Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
Youge Qu, Chun Yang, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Sci Rep 2017
Youge Qu, Chun Yang, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Sci Rep 2017
50
Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders.
Kristen Springer, Nissi Varghese, Anastasios V Tzingounis. Dev Neurosci 2021
Kristen Springer, Nissi Varghese, Anastasios V Tzingounis. Dev Neurosci 2021
50
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
50
Ketamine; history and role in anesthetic pharmacology.
Kazuyoshi Hirota, David G Lambert. Neuropharmacology 2022
Kazuyoshi Hirota, David G Lambert. Neuropharmacology 2022
100
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
50
PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.
E F DOMINO, P CHODOFF, G CORSSEN. Clin Pharmacol Ther 1965
E F DOMINO, P CHODOFF, G CORSSEN. Clin Pharmacol Ther 1965
50
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Veronique E Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J Yuen, Julia M Ruckh, Jennifer L Shadrach, Peter van Wijngaarden, Amy J Wagers, Anna Williams, Robin J M Franklin,[...]. Nat Neurosci 2013
Veronique E Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J Yuen, Julia M Ruckh, Jennifer L Shadrach, Peter van Wijngaarden, Amy J Wagers, Anna Williams, Robin J M Franklin,[...]. Nat Neurosci 2013
50
Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression.
Yentl Y van der Zee, Lars M T Eijssen, Philipp Mews, Aarthi Ramakrishnan, Kelvin Alvarez, Casey K Lardner, Hannah M Cates, Deena M Walker, Angélica Torres-Berrío, Caleb J Browne,[...]. Mol Psychiatry 2022
Yentl Y van der Zee, Lars M T Eijssen, Philipp Mews, Aarthi Ramakrishnan, Kelvin Alvarez, Casey K Lardner, Hannah M Cates, Deena M Walker, Angélica Torres-Berrío, Caleb J Browne,[...]. Mol Psychiatry 2022
50
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
50
Mechanisms of action of fluvoxamine for COVID-19: a historical review.
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto. Mol Psychiatry 2022
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto. Mol Psychiatry 2022
50
New antidepressants: New day or false dawn?
Luke A Jelen, Allan H Young. Eur Neuropsychopharmacol 2022
Luke A Jelen, Allan H Young. Eur Neuropsychopharmacol 2022
50
What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?
Kenji Hashimoto, Yukihiko Shirayama. Biol Psychiatry 2018
Kenji Hashimoto, Yukihiko Shirayama. Biol Psychiatry 2018
50
Mu-opioid receptor and CREB activation are required for nicotine reward.
Carrie L Walters, Jessica N Cleck, Yuo-chen Kuo, Julie A Blendy. Neuron 2005
Carrie L Walters, Jessica N Cleck, Yuo-chen Kuo, Julie A Blendy. Neuron 2005
50
The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine.
Li Ma, Kenji Hashimoto. Neuron 2022
Li Ma, Kenji Hashimoto. Neuron 2022
50
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.
Yan Wei, Lijia Chang, Kenji Hashimoto. Mol Psychiatry 2022
Yan Wei, Lijia Chang, Kenji Hashimoto. Mol Psychiatry 2022
50
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
Kenji Hashimoto. Psychiatry Clin Neurosci 2010
Kenji Hashimoto. Psychiatry Clin Neurosci 2010
50
Detrimental Side Effects of Repeated Ketamine Infusions in the Brain.
Kenji Hashimoto. Am J Psychiatry 2016
Kenji Hashimoto. Am J Psychiatry 2016
50
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.
Kinga Sałaciak, Karolina Pytka. Neurosci Biobehav Rev 2022
Kinga Sałaciak, Karolina Pytka. Neurosci Biobehav Rev 2022
50
Ketamine: A tale of two enantiomers.
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
50
Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.
Kai Zhang, Akemi Sakamoto, Lijia Chang, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan, Xingming Wang, Yuko Fujita, Tamaki Ishima,[...]. Eur Arch Psychiatry Clin Neurosci 2021
Kai Zhang, Akemi Sakamoto, Lijia Chang, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan, Xingming Wang, Yuko Fujita, Tamaki Ishima,[...]. Eur Arch Psychiatry Clin Neurosci 2021
50
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.
Gustavo C Medeiros, Todd D Gould, William L Prueitt, Julie Nanavati, Michael F Grunebaum, Nuri B Farber, Balwinder Singh, Sudhakar Selvaraj, Rodrigo Machado-Vieira, Eric D Achtyes,[...]. Mol Psychiatry 2022
Gustavo C Medeiros, Todd D Gould, William L Prueitt, Julie Nanavati, Michael F Grunebaum, Nuri B Farber, Balwinder Singh, Sudhakar Selvaraj, Rodrigo Machado-Vieira, Eric D Achtyes,[...]. Mol Psychiatry 2022
50
Comparative pharmacology of the ketamine isomers. Studies in volunteers.
P F White, J Schüttler, A Shafer, D R Stanski, Y Horai, A J Trevor. Br J Anaesth 1985
P F White, J Schüttler, A Shafer, D R Stanski, Y Horai, A J Trevor. Br J Anaesth 1985
50
Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
Ken Asada, Fumika Sakaue, Tetsuya Nagata, Ji-Chun Zhang, Kie Yoshida-Tanaka, Aya Abe, Makiko Nawa, Kazutaka Nishina, Takanori Yokota. Nucleic Acids Res 2021
Ken Asada, Fumika Sakaue, Tetsuya Nagata, Ji-Chun Zhang, Kie Yoshida-Tanaka, Aya Abe, Makiko Nawa, Kazutaka Nishina, Takanori Yokota. Nucleic Acids Res 2021
50
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.
Ji-Chun Zhang, Wei Yao, Kenji Hashimoto. Curr Neuropharmacol 2016
Ji-Chun Zhang, Wei Yao, Kenji Hashimoto. Curr Neuropharmacol 2016
50
Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice.
Yunfei Tan, Kenji Hashimoto. J Affect Disord 2020
Yunfei Tan, Kenji Hashimoto. J Affect Disord 2020
50
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
50
R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
50
Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
M Kuersten, M Tacke, L Gerstl, H Hoelz, C V Stülpnagel, I Borggraefe. Eur J Med Genet 2020
M Kuersten, M Tacke, L Gerstl, H Hoelz, C V Stülpnagel, I Borggraefe. Eur J Med Genet 2020
50
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).
F X Vollenweider, K L Leenders, I Oye, D Hell, J Angst. Eur Neuropsychopharmacol 1997
F X Vollenweider, K L Leenders, I Oye, D Hell, J Angst. Eur Neuropsychopharmacol 1997
50
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
Chun Yang, Youge Qu, Yuko Fujita, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Transl Psychiatry 2017
Chun Yang, Youge Qu, Yuko Fujita, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Transl Psychiatry 2017
50
Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
K Hirota, H Okawa, B L Appadu, D K Grandy, L A Devi, D G Lambert. Anesthesiology 1999
K Hirota, H Okawa, B L Appadu, D K Grandy, L A Devi, D G Lambert. Anesthesiology 1999
50
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
50
Assessment of Ketamine and Its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness.
Jackie Zhu, Elisa Hawkins, Kristin Phillips, Laxmikant S Deshpande. Int J Environ Res Public Health 2020
Jackie Zhu, Elisa Hawkins, Kristin Phillips, Laxmikant S Deshpande. Int J Environ Res Public Health 2020
50
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
50
Mapping consent practices for outpatient psychiatric use of ketamine.
David S Mathai, Scott M Lee, Victoria Mora, Kelley C O'Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord 2022
David S Mathai, Scott M Lee, Victoria Mora, Kelley C O'Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord 2022
100
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
50
N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.
Edward James, Joachim Keppler, Thomas L Robertshaw, Ben Sessa. Hum Psychopharmacol 2022
Edward James, Joachim Keppler, Thomas L Robertshaw, Ben Sessa. Hum Psychopharmacol 2022
50
The opioid system in depression.
Luke A Jelen, James M Stone, Allan H Young, Mitul A Mehta. Neurosci Biobehav Rev 2022
Luke A Jelen, James M Stone, Allan H Young, Mitul A Mehta. Neurosci Biobehav Rev 2022
50
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression.
Xingming Wang, Jianjun Yang, Kenji Hashimoto. Neurosci Biobehav Rev 2022
Xingming Wang, Jianjun Yang, Kenji Hashimoto. Neurosci Biobehav Rev 2022
50
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
Nolan R Williams, Boris D Heifets, Brandon S Bentzley, Christine Blasey, Keith D Sudheimer, Jessica Hawkins, David M Lyons, Alan F Schatzberg. Mol Psychiatry 2019
Nolan R Williams, Boris D Heifets, Brandon S Bentzley, Christine Blasey, Keith D Sudheimer, Jessica Hawkins, David M Lyons, Alan F Schatzberg. Mol Psychiatry 2019
50
Neurobiology of depression.
Eric J Nestler, Michel Barrot, Ralph J DiLeone, Amelia J Eisch, Stephen J Gold, Lisa M Monteggia. Neuron 2002
Eric J Nestler, Michel Barrot, Ralph J DiLeone, Amelia J Eisch, Stephen J Gold, Lisa M Monteggia. Neuron 2002
50
Is (S)-norketamine an alternative antidepressant for esketamine?
Kenji Hashimoto, Chun Yang. Eur Arch Psychiatry Clin Neurosci 2019
Kenji Hashimoto, Chun Yang. Eur Arch Psychiatry Clin Neurosci 2019
50
Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain.
Lene Cecilie Mathisen, Per Skjelbred, Lasse A Skoglund, Ivar Øye. Pain 1995
Lene Cecilie Mathisen, Per Skjelbred, Lasse A Skoglund, Ivar Øye. Pain 1995
50
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.
Bangkun Yang, Qian Ren, Min Ma, Qian-Xue Chen, Kenji Hashimoto. Int J Neuropsychopharmacol 2016
Bangkun Yang, Qian Ren, Min Ma, Qian-Xue Chen, Kenji Hashimoto. Int J Neuropsychopharmacol 2016
50
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.
Kenji Hashimoto. Clin Psychopharmacol Neurosci 2014
Kenji Hashimoto. Clin Psychopharmacol Neurosci 2014
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.